Paragraph 2
The game-changing
could make life much easier for those hoping to shed
, and for people with diabetes. Eli Lilly Chief Scientific Officer Dan Skovronsky said: "For the
of patients, this could be the
medicine that they need to control their type 2
as well as their obesity." Currently, the drug is administered in the form of a once-weekly
via an injectable pen. The pen has to be refrigerated. Mr Custer told
: "If approved, we are ready to offer a
, once-daily pill that can be scaled globally, removing
and redefining how obesity is treated around the world." It is also
that the new treatment will be cheaper.
